Skip to main content

Stocks

AI Stock Screener ALVIS Describe a screen in plain English — or filter by any metric across every US-listed stock. One free screen — no signup

Short interest & flow

Most Shorted Highest short interest
Squeeze Risk Composite short-squeeze score
Largest Short Volume Daily short-volume leaders
Highest Off-Exchange Share Dark-pool / OTC volume leaders

Ownership & fundamentals

Insider Sentiment Where insiders are accumulating most
Largest Buybacks Biggest share-repurchase programs
Going-Concern Flags Companies disclosing going-concern doubt

Institutions

Filers & Rankings

Browse Filers All 13F institutional filers
Top by AUM Largest filers by assets
Smart Money Index Top funds' highest-conviction basket
Superinvestors Famous value investors' portfolios
AUM Movers Biggest assets-under-management swings
Most-Held Stocks Stocks owned by the most filers
Last Quarter's Movers Notable position changes
Overlap Matrix Compare filer portfolios side by side
Clone Backtest Backtest a combined clone of several filers
Beneficial Ownership Recent 13D / 13G >5% stakes

13F Activity

13F Statistics Aggregate filing statistics
Latest Filings Newest 13F submissions
13F Trends Sector and flow trends
Double-Down Report Increased-conviction buys
Conviction Heat Map Crowded positions at a glance

Markets

Insider Trading Corporate insider buys and sells
Funds & ETFs Registered funds and ETFs from Form NPORT-P
Investment Advisers SEC-registered Form ADV firms
Economic Data Federal Reserve and macro indicators
Economic Calendar Upcoming macro data releases
FDA Calendar Upcoming FDA advisory-committee meetings
IPO Feed S-1 registrations turned into structured data
Congress Net Worth Richest members by disclosed net worth
Congress Leaderboard Members ranked by portfolio performance

Resources

Research Data-driven market research & single-stock theses
Blog Guides to filings & financials, plus tool comparisons
Announcements Product updates, new data & milestones

Docs Pricing ALVIS AI

Log in Start free

Menu

Docs Pricing ALVIS AI

Start free Log in

Stocks

AI Stock Screener ALVIS

Short interest & flow

Most Shorted Squeeze Risk Largest Short Volume Highest Off-Exchange Share

Ownership & fundamentals

Insider Sentiment Largest Buybacks Going-Concern Flags

Institutions

Filers & Rankings

Browse Filers Top by AUM Smart Money Index Superinvestors AUM Movers Most-Held Stocks Last Quarter's Movers Overlap Matrix Clone Backtest Beneficial Ownership

13F Activity

13F Statistics Latest Filings 13F Trends Double-Down Report Conviction Heat Map

Markets

Insider Trading Funds & ETFs Investment Advisers Economic Data Economic Calendar FDA Calendar IPO Feed Congress Net Worth Congress Leaderboard

Resources

Research Blog Announcements

Stocks
MLYS
Earnings Calls
FY2023 Q1

← Back to all earnings calls

Mineralys Therapeutics, Inc. Q1 FY2023 Earnings Call

Mineralys Therapeutics, Inc. (MLYS)

Earnings Call FY2023 Q1 Call date: 2023-05-15 Concluded

Quarter scorecard

Diluted EPS

$-0.51

Net income

-$12.61M

Documents & deck

Item 2.02 release filed 2023-05-15 Open reading view

The quarterly report covering this quarter (filed 2023-05-15) Open reading view

© 2026 Equibles

Stocks Research Blog Announcements Docs MCP API Datasets Data & API Pricing About Terms Privacy Contact

Please leave this field empty

Report a Problem

Category

Description

Email (optional, for follow-up)